Goldberg Michael

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$964,110.00
Insider Sells Quantity
23
Insider Sells Sum
$22.12M

Insider Activity of Goldberg Michael

The largest purchase of all time was on 2014-07-22 and amounted to 50000 shares of CareDx, Inc for $500,000.

The largest sale of all time was on 2021-05-11 and amounted to 98166 shares of CareDx, Inc for $6.54M.

Biography of Goldberg Michael

No biography is available at this moment.

2022-04-11SaleCareDx, Inc
CDNA
500
0.0009%
$36.01$18,006-52.42%
2022-03-09SaleCareDx, Inc
CDNA
500
0.0009%
$33.41$16,704-44.06%
2022-02-09SaleCareDx, Inc
CDNA
director
500
0.0009%
$42.96$21,480-52.92%
2022-01-10SaleCareDx, Inc
CDNA
director
500
0.0009%
$42.97$21,485-49.62%
2021-12-09SaleCareDx, Inc
CDNA
director
500
0.001%
$45.41$22,705-42.19%
2021-11-09SaleCareDx, Inc
CDNA
director
500
0.001%
$47.54$23,770-43.97%
2021-10-11SaleCareDx, Inc
CDNA
director
500
0.0009%
$62.50$31,251-47.6%
2021-05-11SaleCareDx, Inc
CDNA
director
98,166
0.1904%
$66.60$6.54M-27.76%
2021-05-10SaleCareDx, Inc
CDNA
director
30,884
0.0612%
$68.94$2.13M-28.47%
2020-12-14SaleCareDx, Inc
CDNA
director
60,000
0.1193%
$64.05$3.84M+6.15%
2020-05-11SaleCareDx, Inc
CDNA
director
20,000
0.0445%
$29.86$597,256+79.8%
2020-05-07SaleeHealth, Inc.
EHTH
director
4,750
0.0179%
$115.00$546,250-37%
2020-05-05SaleeHealth, Inc.
EHTH
director
2,000
0.0077%
$110.00$220,000-32.23%
2020-04-30SaleeHealth, Inc.
EHTH
director
2,000
0.0078%
$110.00$220,000-30.87%
2019-08-23SaleeHealth, Inc.
EHTH
director
11,104
0.0481%
$97.58$1.08M+2.8%
2019-08-22SaleeHealth, Inc.
EHTH
director
7,013
0.03%
$102.15$716,360-3.13%
2019-08-21SaleeHealth, Inc.
EHTH
director
4,057
0.0173%
$102.21$414,673-3.07%
2019-05-30SaleeHealth, Inc.
EHTH
director
8,750
0.0371%
$70.00$612,500+32.98%
2019-05-08SaleeHealth, Inc.
EHTH
director
7,500
0.0329%
$63.23$474,224+47.76%
2019-03-14SaleCareDx, Inc
CDNA
director
100,000
0.2353%
$37.36$3.74M-32.2%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.